2022 Annual Meeting | S24 - Epilepsy/Clinical Neurophysiology (EEG): Clinical Epilepsy

Date Tuesday 04/05/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Angela Wabulya, MB ChB, Ahmed M. Yassin, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Erin Jackson
03:30 PM - 03:42 PM PDT	Abstract	001 - The New-Onset Refractory Status Epilepticus (NORSE/FIRES) Family Registry Karnig Kazazian
03:42 PM - 03:54 PM PDT	Abstract	002 - Limited resection preserved verbal memory outcome in drug-resistant dominant temporal lobe epilepsy due to temporal encephaloceles Kelsey M. Smith, MD
03:54 PM - 04:06 PM PDT	Abstract	003 - Brain Temperature Elevations Parallel Unrestricted Water Movement And Increased Myelination In Temporal Lobe Epilepsy Jerzy P. Szaflarski, MD, PhD, FAAN
04:06 PM - 04:18 PM PDT	Abstract	004 - Comparison of nationwide trends in 30-day readmission rates after laser interstitial thermal therapy (LITT) and open surgical procedures for refractory epilepsy (Nationwide Readmission database 2012-2018) Varun Kumar, MD
04:18 PM - 04:30 PM PDT	Abstract	005 - Long-Term Cardiovascular Safety of Fenfluramine for Lennox-Gastaut Syndrome: Interim Analysis of Open-Label Safety Study Pierre Wong, MD
04:30 PM - 04:42 PM PDT	Abstract	006 - Therapeutic Basis of Generic Substitution of Antiseizure Medications Sarah Elmer
04:42 PM - 04:54 PM PDT	Abstract	007 - Use of Ceribell Rapid-Response EEG in 100 consecutive cases correlated with a reduction in anti-seizure medication usage Deepika Kurup
04:54 PM - 05:06 PM PDT	Abstract	008 - Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy Brad K. Kamitaki, MD
05:06 PM - 05:18 PM PDT	Abstract	009 - Outcomes and Resource Utilization Associated with Readmissions after laser interstitial thermal therapy for refractory epilepsy: A Nationwide Readmission database study (2010-2018) Varun Kumar, MD
05:18 PM - 05:30 PM PDT	Abstract	010 - Frequency of New Onset Seizures Amongst Adult Hospitalized Patients with COVID-19; A Systematic Review and Meta-Analysis Daniah Shamim, MD

Faculty Disclosures
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
	No disclosure on file
Brad K. Kamitaki, MD	Dr. Kamitaki has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brown and Brown Absence Services Group. The institution of Dr. Kamitaki has received research support from American Epilepsy Society. The institution of Dr. Kamitaki has received research support from New Jersey Health Foundation.
Nora Wong	No disclosure on file
Prasanthi Govindarajan	Prasanthi Govindarajan has nothing to disclose.
Phuong Thi Hoang, MD, PhD	Dr. Hoang has nothing to disclose.
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Arnold Gammaitoni, PharmD	Dr. Gammaitoni has received personal compensation for serving as an employee of Zogenix Inc.. Dr. Gammaitoni has received stock or an ownership interest from Zogenix Inc..
Hyunmi Choi, MD	The institution of Dr. Choi has received research support from National Institute of Aging.
Gary Heiman	Gary Heiman has nothing to disclose.
Karnig Kazazian	Mr. Kazazian has nothing to disclose.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Daniah Shamim, MD	Dr. Shamim has nothing to disclose.
Kiran M. Kanth, MD	Dr. Kanth has nothing to disclose.
Zach Davey, DO	Dr. Davey has nothing to disclose.
Varun Kumar, MD	Dr. Kumar has nothing to disclose.
Deepika Kurup	Ms. Kurup has nothing to disclose.
Krista L. Eschbach, MD	The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Anupam Agarwal, MD	Dr. Agarwal has received personal compensation for serving as an employee of ZOGENIX.
Katherine M. Clifford, MD	Dr. Clifford has nothing to disclose.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.
Parisha Bhatia, MD	Dr. Bhatia has nothing to disclose.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Katherine Werbaneth	No disclosure on file
Raquel Farias-Moeller, MD	Dr. Farias-Moeller has nothing to disclose.
Sara E. Hocker, MD, FAAN	The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Pierre Wong, MD	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NorCal/Kaiser. Dr. Wong has received publishing royalties from a publication relating to health care.
Marissa Kellogg, MD, MPH	Dr. Kellogg has nothing to disclose.
Chirag N. Savani, MD	No disclosure on file
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Sarah Elmer	Ms. Elmer has nothing to disclose.
Nicolas Gaspard, MD, PhD	No disclosure on file
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Karl Krecke	Karl Krecke has nothing to disclose.
Varun B. Shah, MD	Dr. Shah has nothing to disclose.
Gail M. Farfel, PhD	Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Durect Corp. Dr. Farfel has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zogenix. Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AvroBio. Dr. Farfel has received intellectual property interests from a discovery or technology relating to health care.
Ayushe A. Sharma	Mrs. Sharma has nothing to disclose.
Jamie J. Van Gompel, MD	Jamie J. Van Gompel, MD has received stock or an ownership interest from Neuroone.
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Mark Warman, MD	Dr. Warman has nothing to disclose.
Angela Wabulya, MB ChB	Dr. Wabulya has nothing to disclose.
Tejinder Singh, MD	Dr. Singh has nothing to disclose.
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
Selim R. Benbadis, MD, FAAN	Dr. Benbadis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Benbadis has received research support from Greenwich/Jazz. The institution of Dr. Benbadis has received research support from SK Lifesciences.
Alfred T. Frontera, Jr., MD	Dr. Frontera has nothing to disclose.
Erin Jackson	Ms. Jackson has nothing to disclose.